About Flare Calculator



Basics

The Flare Calculator is meant to help patients and providers estimate how likely it is that a given Flare's symptoms are from gout. It is NOT a diagnostic tool, but intended to be used in conjunction with a provider's clinical judgement. It should help reassure providers that they are on the right track when thinking about gout, prompt them to seek more information when it is needed, or to consider alternative diagnoses if the symptoms and other supporting data don't fit.


Likelihood

Likelihood is Gouthelper's estimation of how likely it is that the Flare reported is due to gout. This is not a fully evidence-based or quantiative determination. The likelihood is based on the evidence-based Diagnostic Rule for gout that Gouthelper expands upon by gathering additional information that experienced providers would consider when evaluating a potential gout flare.

The potential Likelihoods are: Unlikely, Equivocal, and Likely.

The Likelihoods are derived from the Diagnostic Rule's Prevalences and cross-referenced with additional factors about the Flare that increase or decrease the chances that it is gout. For example, if a Flare were medium prevalence (31.2%) by the Diagnostic Rule, but the patient the Flare was reported as diagnosed by a clinican with joint aspiration and crystal analysis showing monosodium urate, then the likelihood would be Likely. Conversely, if the Flare were high prevalence (80.4%) by the Diagnostic Rule, but the Flare was reported as being in a health pre-menopausal woman, then the likelihood would be Equivocal.


Prevalence

Prevalence is a quantitative, evidence-based outcome developed with 2 prospective studies from European medical centers.

The potential Prevalences are: Low (2.2%), Medium (31.2%), and High (80.4%).

Gouthelper's opinion of this work is that it is really cool and helpful. There are a few caveats to their use however. First, these studies only looked at patients who had sudden onset pain in a single joint. Thus, extrapolating this to patients with pain in more than one joint or pain that came on gradually is not supported by the evidence. Second, they didn't include other factors into their final model that are very important practical considerations when clinicians evaluate a patient with gout. This is why Gouthelper gathers additional information about the Flare and integrates that with the Diagnostic Rule to provide a Likelihood.


Interpretation

Likelihoods

Prevalences


Diagnostic Rule

The diagnostic rule is based on really cool work from Dr. Janssens et al. in the Netherlands published in 20101 and 20152.

In 2010 Dr. Janssens' group recruited a large Dutch cohort (n=390) with sudden onset arthritis (pain) in a single joint. They used statistical modeling to determine which factors were most predictive of gout and refined their model into a simple diagnostic rule to stratify participants into three groups by prevalence of gout. Each patient had a joint aspiration as part of the study to confirm or refute the diagnosis, as this is the gold-standard procedure to diagnose gout.

The factors that comprised the final simplified diagnostic rule model were weighted according to their importance and are:

In 2015 their group then validated their diagnostic rule in a different population of Dutch patients who were being seen in a rheumatology referral center. These patients were all suspected as having prior gout flares. The positive predictive value of a score >= 8 was 0.87, meaning gout was highly likely but that there were still alternative but not a complete certainty. The negative predictive value of a score <=4 was 0.95, meaning gout could be ruled out with a high degree of probability.


References

  1. Janssens HJEM, Fransen J, van de Lisdonk EH, van Riel PLCM, van Weel C, Janssen M. A Diagnostic Rule for Acute Gouty Arthritis in Primary Care Without Joint Fluid Analysis. Arch Intern Med. 2010;170(13):1120–1126. doi:10.1001/archinternmed.2010.196
  2. Laura B. E. Kienhorst, Hein J. E. M. Janssens, Jaap Fransen, Matthijs Janssen, The validation of a diagnostic rule for gout without joint fluid analysis: a prospective study, Rheumatology, Volume 54, Issue 4, April 2015. PMID:25231179
Back to top